President Trump Announces Nine New Big Pharma “Most Favored Nation Status” Signees Today – HUGE Implications for Healthcare Costs!
Today, President Donald Trump announced the “Largest Development to Date in Bringing Most-Favored-Nation (MFN) Pricing to American Patients via the White House website and an Oval Office press conference. The new agreements announced this afternoon include nine major pharmaceutical manufacturers, including Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi, and will help “reduce prices on drugs that treat